Library

4,4'-DMAR

4,4'-DMAR is an extremely potent stimulant that is 5-10 times more potent than MDMA as a monoamine releasing agent. It has pharmacological properties comparable to MDMA but with higher potency and longer duration. Unlike many amphetamines, 4,4'-DMAR lacks TAAR1 agonism, meaning it does not auto-inhibit its own effects, potentially making it more dangerous. It has been associated with at least 31 fatalities in Europe, often when combined with other substances. Serious health risks include serotonin syndrome, hyperthermia, seizures, cardiovascular complications, and pulmonary hypertension.

Also known as: 4,4-dmap, Serotoni, Serotoni, para-methyl-4-methylaminorex, 4-methyl-euphoria, 4-methyl-U4Euh, Para-methyl-4-methylaminorex

Classification

  • Chemical: Aminorex
  • Psychoactive: Entactogen
  • Psychoactive: Stimulant
  • Tag: Empathogen
  • Tag: Habit-Forming
  • Tag: Research-Chemical
  • Tag: Tentative

Effects

  • Increased Energy
  • Stimulation
  • Physical Energy
  • Teeth Grinding
  • Jaw Tension
  • Sweating And Increased Body Temperature
  • Euphoria
  • Enhanced Focus
  • Increased Sociability
  • Empathogenic Effects
  • Empathy Enhancement
  • Sociability Enhancement
  • Appetite Suppression
  • Light Sensitivity
  • Dehydration
  • Increased Libido
  • Vibrating Vision
  • Disinhibition

Routes of Administration

Oral

Dosage

  • Threshold: ~1–3 mg (anecdotal)
  • Light: ~5–10 mg (anecdotal)
  • Common: ~10–25 mg (anecdotal)
  • Strong: ~25–40 mg (anecdotal)
  • Heavy: >40 mg (high risk; avoid)

Duration

  • Onset: 0.75-2 h
  • Peak: 2-4 h
  • Offset: 2-4 h
  • After Effects: 9-24 h
  • Total Duration: 8-14 h

Insufflated

Dosage

  • Threshold: ≤1–2 mg (anecdotal)
  • Light: ~2–5 mg (anecdotal)
  • Common: ~5–10 mg (anecdotal)
  • Strong: ~10–20 mg (anecdotal)
  • Heavy: >20 mg (high risk; avoid)

Duration

  • Onset: 0.5-1.5 h
  • Peak: 1.5-4 h
  • Offset: 2-4 h
  • After Effects: 8-24 h
  • Total Duration: 6-12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

4,4'-DMAR - DrugsPRO substancijos vadovas

4,4'-DMAR: 4,4'-DMAR is an extremely potent stimulant that is 5-10 times more potent than MDMA as a monoamine releasing agent. It has pharmacological properties comparable to MDMA but with higher potency and longer duration. Unlike many amphetamines, 4,4'-DMAR lacks TAAR1 agonism, meaning it does no

Related pages